Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant)

Ann Hematol. 2010 Feb;89(2):217-9. doi: 10.1007/s00277-009-0795-6. Epub 2009 Jul 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Castleman Disease / complications*
  • Castleman Disease / drug therapy*
  • Castleman Disease / pathology
  • Humans
  • Male
  • Middle Aged
  • POEMS Syndrome / complications*
  • POEMS Syndrome / drug therapy*
  • POEMS Syndrome / pathology
  • Protease Inhibitors / therapeutic use*
  • Pyrazines / therapeutic use*
  • Treatment Outcome

Substances

  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib